A detailed history of Citigroup Inc transactions in Liva Nova PLC stock. As of the latest transaction made, Citigroup Inc holds 47,111 shares of LIVN stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,111
Previous 260,603 81.92%
Holding current value
$2.2 Million
Previous $14.3 Million 82.69%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$43.38 - $54.59 $9.26 Million - $11.7 Million
-213,492 Reduced 81.92%
47,111 $2.47 Million
Q2 2024

Aug 12, 2024

BUY
$51.76 - $64.15 $2.45 Million - $3.03 Million
47,254 Added 22.15%
260,603 $14.3 Million
Q1 2024

May 10, 2024

BUY
$48.6 - $57.12 $9.9 Million - $11.6 Million
203,781 Added 2129.82%
213,349 $11.9 Million
Q4 2023

Feb 09, 2024

BUY
$43.45 - $53.66 $322,616 - $398,425
7,425 Added 346.48%
9,568 $495,000
Q3 2023

Nov 09, 2023

SELL
$50.12 - $58.87 $958,645 - $1.13 Million
-19,127 Reduced 89.92%
2,143 $113,000
Q2 2023

Aug 10, 2023

BUY
$42.28 - $51.43 $584,774 - $711,328
13,831 Added 185.93%
21,270 $1.09 Million
Q1 2023

May 11, 2023

BUY
$40.84 - $58.14 $30,630 - $43,605
750 Added 11.21%
7,439 $324,000
Q4 2022

Feb 09, 2023

SELL
$43.88 - $56.16 $258,540 - $330,894
-5,892 Reduced 46.83%
6,689 $371,000
Q3 2022

Nov 10, 2022

BUY
$48.37 - $66.5 $150,769 - $207,280
3,117 Added 32.94%
12,581 $639,000
Q2 2022

Aug 10, 2022

BUY
$57.25 - $86.63 $116,961 - $176,985
2,043 Added 27.53%
9,464 $591,000
Q1 2022

May 12, 2022

SELL
$71.02 - $86.99 $2.28 Million - $2.79 Million
-32,075 Reduced 81.21%
7,421 $607,000
Q4 2021

Feb 10, 2022

BUY
$76.72 - $92.68 $1.22 Million - $1.48 Million
15,965 Added 67.85%
39,496 $3.45 Million
Q3 2021

Nov 10, 2021

BUY
$76.02 - $88.62 $1.79 Million - $2.09 Million
23,531 New
23,531 $1.86 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.